摩根大通於全球系統重要性銀行名列榜首 中資銀行位置不變
金融穩定委員會(FSB)與巴塞爾銀行監管委員會 (BCBS)公佈今年度全球系統重要性銀行排名,在上榜的30家銀行中,摩根大通(JPM.US)再次被評爲對全球整體金融系統健康最重要的銀行。
名單根據銀行的規模、相互關聯性、服務可替代性、國際性及系統性等排名。今年摩根大通由第三檔升至第四檔;法國巴黎銀行從第二檔升至第三檔,與花旗(C.US)和匯控(00005.HK)並列;高盛則從第一檔移到第二檔。目前第五檔爲懸空。
而中資銀行今年檔位不變,中國銀行(03988.HK)、建設銀行(00939.HK)和工商銀行(01398.HK)仍位列第二檔。農業銀行(01288.HK)則排在第一檔。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.